3,4-Methylenedioxy-N-hydroxy-N-methylamphetamine
Source: Wikipedia, the free encyclopedia.
Chemical compound
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
JSmol) | |
|
3,4-Methylenedioxy-N-hydroxy-N-methylamphetamine (MDHMA; FLEA) is an
MDOH. MDHMA was first synthesized and assayed by Alexander Shulgin.[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin listed the dosage range as 100–160 mg, and the duration as approximately 4–8 hours.[1] He describes MDHMA as causing entactogenic and open MDMA-like effects, easing communication, and increasing appreciation of the senses.[1]
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
References
- ^ OCLC 25627628.
- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
External links
| |
---|---|
Phenylalkyl- amines (other than cathinones) |
|
Cyclized phenyl- alkylamines | |
Cathinones | |
Tryptamines |
|
Chemical classes |
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|